Sponsor of the Day:
Jerkmate
https://investors.alnylam.com/press-releases
Press Releases | Alnylam Pharmaceuticals, Inc.
Read our most recent press releases and search through our archive of releases.
alnylam pharmaceuticals incpress releases
https://investors.alnylam.com/financial-information
Financial Information | Alnylam Pharmaceuticals, Inc.
See reports, filings, and documents that include details of our financial performance.
alnylam pharmaceuticals incfinancial information
https://investors.alnylam.com/events
Events and Presentations | Alnylam Pharmaceuticals, Inc.
Find our upcoming events and listen to webcasts from past events.
alnylam pharmaceuticals inceventspresentations
https://investors.alnylam.com/ownership-profile
Ownership Profile | Alnylam Pharmaceuticals, Inc.
View a detailed shareholder breakdown for Alnylam Pharmaceuticals.
alnylam pharmaceuticals incownershipprofile
https://investors.alnylam.com/press-release?id=27761
Alnylam Pharmaceuticals Press Release | Oct 25, 2023 | Alnylam Reports Additional Positive Interim...
Alnylam Reports Additional Positive Interim Phase 1 Results for ALN-APP, in Development for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
pharmaceuticals press releaseoct 252023 reportsalnylamadditional
https://investors.alnylam.com/investor-toolkit
Investor Toolkit | Alnylam Pharmaceuticals, Inc.
Find our most recent financial information, including filings, releases, reports, and more.
alnylam pharmaceuticals incinvestor toolkit
https://investors.alnylam.com/press-release?id=22946
Alnylam Pharmaceuticals Press Release | Aug 10, 2018 | Alnylam Announces First-Ever FDA Approval of...
Alnylam Announces First-Ever FDA Approval of an RNAi Therapeutic, ONPATTRO™ (patisiran) for the Treatment of the Polyneuropathy of Hereditary...
pharmaceuticals press releaseannounces first everaug 10fda approvalalnylam
https://www.greatplacetowork.com/certified-company/1324817
Working at Alnylam Pharmaceuticals | Great Place To Work®
Is Alnylam Pharmaceuticals a great place to work for?
alnylam pharmaceuticalsgreat placeworking
https://tradingeconomics.com/alny:us:sales
Alnylam Pharmaceuticals | ALNY - Sales Revenues
Alnylam Pharmaceuticals reported $1.17B in Sales Revenues for its fiscal quarter ending in March of 2026.Data for Alnylam Pharmaceuticals | ALNY - Sales...
alnylam pharmaceuticalssales revenues
https://jobs.alnylam.com/careers
Careers at Alnylam Pharmaceuticals
alnylam pharmaceuticalscareers
https://www.alnylam.jp/
Alnylam® Pharmaceuticals | Alnylam Japan
pharmaceuticalsalnylamjapan
https://www.alnylam.de/
Alnylam® Pharmaceuticals | Deutschland | Alnylam-de
pharmaceuticalsdeutschlandalnylam